Variant report
Variant | nsv968156 |
---|---|
Chromosome Location | chr5:29067610-29071379 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr5:29070987-29071060 | K562 | blood: | n/a | n/a |
2 | FOXA1 | chr5:29068731-29069068 | HepG2 | liver: | n/a | n/a |
3 | JUN | chr5:29070574-29070705 | K562 | blood: | n/a | n/a |
4 | MAFK | chr5:29067592-29067660 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | MXI1 | chr5:29070547-29070574 | K562 | blood: | n/a | n/a |
6 | NFYB | chr5:29067722-29067724 | Hela-S3 | cervix: | n/a | n/a |
7 | NFYB | chr5:29068912-29069112 | GM12878 | blood: | n/a | n/a |
8 | POLR2A | chr5:29069125-29069157 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:29059482..29062466-chr5:29065874..29068673,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDH6-3 | chr5:29066381-29070363 | ENSG00000249322 |
2 | lnc-CDH6-3 | chr5:29066381-29070363 | NR_109948 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000252601 | TF binding region |
CBFB | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576713771 | chr5:29067648-29067649 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs188340852 | chr5:29067652-29067653 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs545554904 | chr5:29067667-29067668 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs148098805 | chr5:29067711-29067712 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs191333333 | chr5:29067741-29067742 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs489449 | chr5:29067743-29067744 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs117758094 | chr5:29067781-29067782 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs199882853 | chr5:29067789-29067790 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs199819997 | chr5:29067790-29067791 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs574832835 | chr5:29067813-29067814 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs141833936 | chr5:29067883-29067884 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs374382866 | chr5:29067993-29067994 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs368495016 | chr5:29067994-29067995 | Flanking Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs182411830 | chr5:29068001-29068002 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs150701541 | chr5:29068005-29068006 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs201706101 | chr5:29068010-29068011 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs57789984 | chr5:29068011-29068012 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs201493882 | chr5:29068016-29068017 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs61330770 | chr5:29068020-29068021 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs138756265 | chr5:29068022-29068023 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs372635177 | chr5:29068024-29068025 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs200454933 | chr5:29068025-29068026 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs57540117 | chr5:29068028-29068029 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs491503 | chr5:29068031-29068032 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs547389170 | chr5:29068044-29068045 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs569076785 | chr5:29068081-29068082 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs187856303 | chr5:29068137-29068138 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs572648042 | chr5:29068164-29068165 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs78109493 | chr5:29068173-29068174 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs377171986 | chr5:29068175-29068176 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs368802184 | chr5:29068198-29068199 | Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs535192126 | chr5:29068255-29068256 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs548773283 | chr5:29068295-29068296 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs570104537 | chr5:29068308-29068309 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs138931963 | chr5:29068321-29068322 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs80091632 | chr5:29068334-29068335 | Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs515977 | chr5:29068352-29068353 | Enhancers Active TSS | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs516178 | chr5:29068428-29068429 | Active TSS Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs116133028 | chr5:29068439-29068440 | Active TSS Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs192687441 | chr5:29068452-29068453 | Active TSS Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs114740631 | chr5:29068461-29068462 | Active TSS Enhancers Flanking Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs74454748 | chr5:29068619-29068620 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs575479840 | chr5:29068621-29068622 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs569109135 | chr5:29068630-29068631 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs55882562 | chr5:29068639-29068640 | Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs557895172 | chr5:29068649-29068650 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs656260 | chr5:29068698-29068699 | Active TSS Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs528392971 | chr5:29068717-29068718 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs577615663 | chr5:29068719-29068720 | Active TSS Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs540272571 | chr5:29068768-29068769 | Active TSS Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29067600-29067800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
2 | chr5:29067800-29068200 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
3 | chr5:29067800-29068200 | Enhancers | Stomach Mucosa | stomach |
4 | chr5:29068000-29068400 | Enhancers | Rectal Mucosa Donor 29 | rectum |
5 | chr5:29068200-29068400 | Active TSS | Rectal Mucosa Donor 31 | rectum |
6 | chr5:29068400-29068600 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
7 | chr5:29068400-29068600 | Weak transcription | Stomach Mucosa | stomach |
8 | chr5:29068400-29068800 | Active TSS | Pancreatic Islets | Pancreatic Islet |
9 | chr5:29068400-29069200 | Enhancers | Pancreas | Pancrea |
10 | chr5:29068400-29069200 | Enhancers | HepG2 | liver |
11 | chr5:29068400-29070200 | Active TSS | Rectal Mucosa Donor 29 | rectum |
12 | chr5:29068600-29069000 | Active TSS | Rectal Mucosa Donor 31 | rectum |
13 | chr5:29068600-29069000 | Active TSS | Stomach Mucosa | stomach |
14 | chr5:29069000-29069200 | Flanking Active TSS | Stomach Mucosa | stomach |
15 | chr5:29069000-29069400 | Active TSS | Rectal Smooth Muscle | rectum |
16 | chr5:29069000-29069600 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
17 | chr5:29069200-29069600 | Enhancers | Stomach Mucosa | stomach |
18 | chr5:29069600-29070800 | Enhancers | Rectal Mucosa Donor 31 | rectum |